Free Newsletter
Roche helps catch cheating athletes
The campaign against sports cheats has found a new ally in Big Pharma. Roche says it collaborated with anti-doping experts to help catch Tour de France athletes who used its anemia drug Mircera--known as CERA in sports circles--to boost their cycling performance. And now, drug watchdogs will be using that assistance to check the stored blood samples of Olympians, double-checking the honesty of medal-winning athletes.
Roche teamed up with the World Anti-Doping agency in 2004, when clinical trials showed that CERA could help athletes perform better. Together they developed a test to detect athletes' use of the drug. That lab screen found that three stage winners in the 2008 Tour used CERA to boost their ability to compete.
"We were very pleased that this collaboration with WADA has been productive," Roche spokeswoman Claudia Schmitt told the Associated Press. "We are really not happy to see Mircera misused for doping, or to see it in the sports world."
- read the story in the International Herald Tribune
Related Articles:
Performamce-enhancing questions surround ED drug
'Gene doping' may become next steroid
Amgen prevails against Roche's Mircera
Roche appeals Mircera injunction
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





